These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14627174)

  • 61. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
    Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
    J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma.
    Sears MR; Boulet LP; Laviolette M; Fitzgerald JM; Bai TR; Kaplan A; Smiljanic-Georgijev N; Lee JS
    Eur Respir J; 2008 May; 31(5):982-9. PubMed ID: 18216054
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S; Vahteristo M; Metev H; Taseva M; Stamatova N; Bartha A; Schlezák J; Sairanen U
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
    Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study.
    Haahtela T; Tamminen K; Malmberg LP; Zetterström O; Karjalainen J; Ylä-Outinen H; Svahn T; Ekström T; Selroos O
    Eur Respir J; 2006 Oct; 28(4):748-55. PubMed ID: 17012630
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone.
    Löfdahl CG; Ericsson A; Svensson K; Andreasson E
    Pharmacoeconomics; 2005; 23(4):365-75. PubMed ID: 15853436
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
    Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
    BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.
    Eliraz A; Ramirez-Rivera A; Ferranti P; Holzer R; García JM; Turcotte C; Rapatz G; Pfister P; Overend T; Kottakis J
    Int J Clin Pract; 2001 Apr; 55(3):164-70. PubMed ID: 11351769
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A health-related quality-of-life comparison of formoterol (Oxis) Turbuhaler plus budesonide (Pulmicort) Turbuhaler with budesonide Turbuhaler alone and noncorticosteroid treatment in asthma: a randomized clinical study in Russia.
    Chuchalin AG; Svensson K; Ståhl E; Ovcharenko SI; Goriachkina LA; Sidorenko IV; Tsoi AN;
    Respiration; 2002; 69(5):427-33. PubMed ID: 12232450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.
    Lewis A; Torvinen S; Dekhuijzen PN; Chrystyn H; Watson AT; Blackney M; Plich A
    BMC Health Serv Res; 2016 Jul; 16():251. PubMed ID: 27406133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
    FitzGerald JM; Arnetorp S; Smare C; Gibson D; Coulton K; Hounsell K; Golam S; Sadatsafavi M
    Respir Med; 2020 Sep; 171():106079. PubMed ID: 32917353
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study.
    Andersson F; Stahl E; Barnes PJ; Löfdahl CG; O'Byrne PM; Pauwels RA; Postma DS; Tattersfield AE; Ullman A;
    Respir Med; 2001 Jun; 95(6):505-12. PubMed ID: 11421509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mometasone/Formoterol (dulera) for asthma.
    Med Lett Drugs Ther; 2010 Oct; 52(1349):83-4. PubMed ID: 21045758
    [No Abstract]   [Full Text] [Related]  

  • 74. [Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].
    Zyryanov SK; Dyakov IN; Aisanov ZR
    Ter Arkh; 2022 Aug; 94(7):850-858. PubMed ID: 36286942
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pitfalls associated with the therapeutic reference pricing practice of asthma medication.
    Kalo Z; Abonyi-Toth Z; Bartfai Z; Voko Z
    BMC Pulm Med; 2012 Jul; 12():35. PubMed ID: 22818402
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and safety of budesonide/formeterol combination therapy in asthma patients.
    Jakopović M; Pavicić F; Redzepi G; Plestina S; Janković M; Franić Z; Samija M; Samarzija M
    Coll Antropol; 2009 Jun; 33(2):587-91. PubMed ID: 19662783
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research.
    Braido F; Baiardini I; Compalati E; Bordo A; Canonica GW
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):361-74. PubMed ID: 21659859
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control.
    Barnes PJ
    BMJ; 2007 Sep; 335(7618):513. PubMed ID: 17823193
    [No Abstract]   [Full Text] [Related]  

  • 79. ["Real-life"-data on asthma control using budesonide/formoterol for both maintenance and relief: the Swiss experience].
    Steurer-Stey C; Courteheuse C; Taegtmeyer AB; Leuppi JD
    Praxis (Bern 1994); 2009 Nov; 98(23):1335-42. PubMed ID: 19918725
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Budesonide-formoterol (inhalation powder) in the treatment of COPD.
    Ceylan E
    Int J Chron Obstruct Pulmon Dis; 2006; 1(2):115-22. PubMed ID: 18046888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.